Quan Joanne 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Apr 4, 2018
Insider Transaction Report
Form 4
Quan Joanne
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2018-04-02−4,000→ 22,256 totalExercise: $2.06Exp: 2025-09-22→ Common Stock (4,000 underlying) - Sale
Common Stock
2018-04-02$10.00/sh−4,000$40,000→ 0 total - Exercise/Conversion
Common Stock
2018-04-02$2.06/sh+4,000$8,240→ 4,000 total
Footnotes (1)
- [F1]25% of the option vested on April 14, 2016 and the remaining shares vest in successive equal monthly installments for the subsequent 36 months subject to Reporting Person's continuous service status as of each such date.